Trials / Conditions / Amyloid Light-chain Amyloidosis
Amyloid Light-chain Amyloidosis
4 registered clinical trials studyying Amyloid Light-chain Amyloidosis — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain ( NCT07524634 | Case Comprehensive Cancer Center | Phase 2 |
| Recruiting | Teclistamab-Daratumumab in AL Amyloidosis NCT07110844 | Suzanne Lentzsch, MD | Phase 2 |
| Recruiting | Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Trea NCT06455748 | Yongyong MA | N/A |
| Terminated | A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple My NCT05839626 | Sanofi | Phase 1 / Phase 2 |